Solubilization polymer AFFINISOL ™ series

a. a.

Solve difficult soluble problems

Hot-melt extrusion (HME) dedicated AFFINISOL ™ hydroxypropyl methyl cellulose

Drug solubility difference of active ingredient (API) is a major challenge facing the pharmaceutical industry.AFFINISOL ™ polymer for solubilization needs to solve these drugs active ingredient and customized.

AFFINISOL ™ HPMC HME polymer

AFFINISOL ™ HPMC HME (hot melt extrusion type hydroxypropyl methyl cellulose) designed for hot melt extrusion formula design, pharmaceutical companies through the use of this polymer, to improve the solubility and suppress API API recrystallization.

As a kind of cellulose polymers, AFFINISOL ™ HPMC HME not only have the hydroxypropyl methylcellulose common crystallization inhibition performance, and without use of plasticizer in a wider temperature range hot melt extrusion.At the same time, AFFINISOL ™ HPMC HME can simplify formula requirements, improve the physical stability, and provides various functions in drug release curve.

The application of AFFINISOL ™ series polymer

AFFINISOL ™ series polymer is dedicated to solve the problem of solubilization of API performance requirements and customized.

HME as formula technology applied to the pharmaceutical industry is rapidly developing, using the two technologies will increase the biopharmaceutics classification system in class II and class IV of the solubility of difficult soluble drugs, and prevent nucleation.

AFFINISOL ™ is a registered trademark IFF company.© 2021 IFF. All rights reserved

Product literature

posters

Technology platform solutions

Through the selection of materials and process guidance, card nu-lax can provide the right solution for you and help you shorten the project time.

The production efficiency

a.

Design of dissolution

a.

Patient compliance

a.

The stability of

a.

Preparations of anti-counterfeiting technology

a.